e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Lung cancer: molecular pathology and functional genomics
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of four different molecular methods for EGFR mutation analysis in exon 18, 19 and 21
A. Streubel, A. Roth, S. Stephan-Falkenau, O. Landt, C. Götz, T. Mairinger (Berlin, Germany)
Source:
Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Session:
Lung cancer: molecular pathology and functional genomics
Session type:
Poster Discussion
Number:
1958
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Streubel, A. Roth, S. Stephan-Falkenau, O. Landt, C. Götz, T. Mairinger (Berlin, Germany). Evaluation of four different molecular methods for EGFR mutation analysis in exon 18, 19 and 21. Eur Respir J 2011; 38: Suppl. 55, 1958
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Diagnostic utility of PNA-LNA PCR clamp method for detection of EGFR exon 19 deletions and exon 21 codon L858 mutations in NSCLC samples with low tumor cells content
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012
Evaluation of PNA-LNA PCR clamp method sensitivity for detection of key EGFR gene exon 19 and exon 21 mutations
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012
FGFR1-4 and MET expression analysis and evaluation of reliable reference genes in Sq-NSCLC
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Target other gene point mutations: HER2 and rare EGFR mutations
Source: ERS Research Seminar
Year: 2015
Molecular profiling of Sq-NSCLC with enhanced FGFR1-4 and MET gene expression – NGS pilot study.
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Detection of k-ras codon 12 mutations in human lung tumour tissue by REMS-PCR
Source: Eur Respir J 2001; 18: Suppl. 33, 233s
Year: 2001
Exon 22 A3650G, Intron 27 T520C and Exon 33 C5507G polymorphisms of complement receptor 1 gene are associated with idiopathic pulmonary fibrosis
Source: Annual Congress 2003 - Immunology of interstitial lung diseases
Year: 2003
Biological analysis of the single codon deletion in Exon 19 of EGF receptor in non-small cell lung cancer responsive to gefitinib
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
Very early detection of small clones harbouring EGFR mutations in NSCLC by 2nd generation sequencing
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Rescue of CFTR function impaired by mutations in exon 15
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020
Gefitinib as first-line treatment for patients with NSCLC with activating EGFR mutationin exons 19 (Del19) or 21 (L858R) in the Czech Republic
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Late Breaking Abstract: Real-time PCR versus direct sequencing in detection of EGFR T790M and L858R mutations – The sensitivity comparison
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Identification and characterisation of seven novel SERPINA1 null mutations
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014
Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients
Source: Eur Respir Rev 2014; 23: 390-392
Year: 2014
Validation of PNA-LNA PCR clamp assay for detection of EGFR exon 19 and 21 mutations in various types of clinical non-small cell lung cancer specimens
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
The downstream effects of the 17q12-21 asthma region. Is functional splicing of GSDMB the explanation?
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020
Description of new CFTR gene’s mutations in patients of Russia
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
Evaluation of
MRP1-5
gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation
Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies
Year: 2003
Analysis of the human SP-A 5‘UTR exon B: Identification of regulatory regions
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept